The Pharma Shake-Up: 7 Opportunities Redefining Manufacturing in the UK & Ireland (2026 and beyond)
By Harriette Wysocki, Pharma Business Manager
Pharma isn’t standing still - and neither should the technology behind it.
In 2026, the way medicines are made, licensed, and monitored is changing faster than ever.
The UK is rolling out a new International Recognition Procedure, cutting approval times by trusting decisions from global regulators like the FDA and EMA. Meanwhile, Ireland’s HPRA continues to anchor the EU’s gold-standard GMP framework - keeping scrutiny sharp but collaboration open.
The goal on both sides of the Irish Sea is clear: faster access, safer medicines, and smarter manufacturing.
And for those of us working behind the scenes, that shift brings seven very real challenges - and therefore, seven huge opportunities.
1. Digital transformation that actually scale
Everyone’s talking about “digitalisation,” but in most plants it still lives in PowerPoint slides and pilot lines.
Legacy equipment, fragmented data, and endless validation slow everything down.
Opportunity: Edge computing and rugged mobile devices now make it possible to collect and validate data right where work happens - in cleanrooms, production zones, or QA labs - and sync it securely to enterprise systems in real time.
Because true transformation only counts when it leaves the boardroom and reaches the shop floor.
2. Flexible manufacturing: from one-size-fits-all to made-to-order
Precision medicine, biologics, and personalised therapies have killed the era of mass uniform production.
Smaller batches, faster changeovers, and higher traceability are the new reality.
Opportunity: Modular production systems and cleanroom-ready tech that moves with the process - giving operators instant access to SOPs and batch data without contamination risk.
Agility isn’t optional anymore; it’s a GMP expectation.
3. Biomanufacturing and advanced therapies take centre stage
Biologics, cell and gene therapies are rewriting what “medicine” means - but they’re fragile.
One missed reading, one temperature drift, one unlogged sample, and the entire batch is gone.
Opportunity: Secure, disinfectant-ready devices that survive 24/7 cleanroom conditions, supporting digital batch records and process analytics that regulators like the HPRA and MHRA can trust.
The future of medicine depends on precision, and precision depends on reliability.
4. Data integrity and cybersecurity become regulatory DNA
The MHRA’s faster approval pathway means decisions will rely on the strength of evidence, not red tape.
That means every connected device in your operation must be validated, traceable, and secure.
Opportunity: Zero-trust architecture, BIOS-level protection, and full audit trails - so quality, IT, and compliance teams all sleep at night.
Security isn’t an afterthought, it’s part of your licence to operate.
5. Supply chains under the microscope
The pandemic exposed how fragile global pharma logistics really were.
Add rising demand for counterfeit vigilance and new “UK-Only” labelling rules, and transparency is everything.
Opportunity: Barcode and RFID tracking, real-time proof-of-delivery, and chain-of-custody data collected on rugged mobile devices - ensuring every movement from Cork to Cambridge is visible and verifiable.
6. Sustainability that pays off
Energy, water, plastics - regulators and shareholders alike want numbers, not promises.
The IPHA’s 2025 Code of Practice now links sustainability to corporate responsibility, while UK plants face growing environmental disclosure requirements.
Opportunity: Edge devices that capture live resource data and feed ESG dashboards, turning environmental insight into cost savings and credibility.
Greener operations aren’t a PR goal - they’re a profitability strategy.
7. Bridging the human-technology gap
No matter how smart the system, people still make it work.
Engineers, QA staff, and operators need tech that fits their world - not the other way around.
Opportunity: Build adoption from the ground up with intuitive, durable tools that work under pressure - in gloves, bright light, or long shifts.
Because digital transformation isn’t about replacing people; it’s about empowering them.
Looking ahead
The UK and Ireland are leading a quiet revolution - faster approvals, smarter manufacturing, cleaner operations.
The real question isn’t whether the industry will change, but who’s ready to adapt first.
From cleanroom-ready tablets to real-time edge analytics, Panasonic TOUGHBOOK is helping pharmaceutical teams turn regulatory pressure into practical progress - one validated device at a time.
Read more insights…
blog
Top Field Management Software (FMS) for 2026
UK organisations in utilities, logistics, public services, and maintenance are rethinking how they schedule, deploy, and support their mobile teams.
blog
Top 5 Microsoft Copilot for Microsoft 365 Features That Field Teams Will Actually Use
Some of the latest updates to Microsoft Copilot for Microsoft 365 are surprisingly practical
whitepaper
EMERGENCY RESPONSE: THE DIGITAL AGE OF EMERGENCY MEDICINE
Emergency healthcare is being transformed by technologies like 5G, AI, and augmented reality, enabling faster, more effective treatment directly in ambulances and improving real-time collaboration with hospitals.
blog
Driving Field Efficiency: Why Reliable, Future-Proof Devices Matter More Than Ever
When a device breaks or fails, the impact ripples far beyond the hardware. For field teams, every minute offline means lost productivity, delayed service delivery, and frustrated customers.
Sorry there was an error...
The files you selected could not be downloaded as they do not exist.
You selected items.
Continue to select additional items or download selected items together as a zip file.
You selected 1 item.
Continue to select additional items or download the selected item directly.
Share page
Share this link via:
Twitter
LinkedIn
Xing
Facebook
Or copy link: